Back to: Research
Policies and Guidelines
- Biologically Active Agents Used in CAM and Placebo Materials--Policy and Guidance
- Guidelines for NCCAM-supported Clinical Trials
- Applying for NCCAM Clinical Trials Grants: Points to Consider
- Considerations for NCCAM Clinical Trial Grant Applications
- Guidance on Designing Clinical Trials of CAM Therapies: Determining Dose Ranges
- NCCAM Terms of Awards for Clinical Trials
- NIH Policy on Data and Safety Monitoring Boards
- Data and Safety Monitoring Guidelines for NCCAM-supported Clinical Trials
- Phase III Clinical Trials
- Adverse Events
- Human Subjects and Animal Protection
- Certificates of Confidentiality (NIH)
- Office for Human Research Protections, DHHS
- Required Education in the Protection of Human Research Participants, NIH
- FAQ on Required Education in the Protection of Human Research Participants
- Human and Animal Subject Protection (PDF)
- Office of Animal Care and Use, NIH
- NIH Grants Policy Statement
- Policy Notices
Note: The PDF file requires a viewer such as Adobe Reader, which you can download free of charge from the Adobe Web site.